Fulvestrant-Carfilzomib as opposed to Letrozole-Palbociclib as Preliminary Treatments regarding Endocrine-Sensitive, Endocrine Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: The Randomized Medical study | #carfilzomib #capmatinib #proto-oncogene tyrosine-protein kinase Src